WallStreetZenWallStreetZen

NASDAQ: VMD
Viemed Healthcare Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Viemed Healthcare earnings were $12.3M for the trailing 12 months ending Mar 31, 2025, with 18.5% growth year over year. The latest VMD earnings report on Mar 31, 2025 announced Q1 2025 earnings of $2.6M, down 39.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VMD reported annual earnings of $11.3M, with 10% growth. The next VMD earnings date is Aug 6, 2025.

VMD past earnings growth

How has VMD's earnings growth performed historically?

Company
18.52%
Industry
50.78%
Market
33.86%
VMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
VMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
VMD's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

VMD earnings history

Current Revenue
$232.8M
Current Earnings
$12.3M
Current Profit Margin
5.3%

VMD Return on Equity

Current Company
9.6%
Current Industry
7.5%
Current Market
31.3%
VMD's Return on Equity (9.6%)... subscribe to Premium to read more.
High Return on Equity Performance

VMD undefined

Current Company
7.1%
Current Industry
8.7%
VMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VMD announces earnings.

VMD undefined

Current Company
12.82%
Current Industry
9.1%
VMD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VMD vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VMD$43.98M$12.29M+1.99%$0.32
CERS-$5.95M-$18.95MN/A-$0.10
ZIMV$42.31M-$19.54MN/A-$0.71
MASS-$13.25M-$17.69MN/A-$0.54
BSGM-$9.32M-$9.79MN/A-$0.59
View Top Medical Device Stocks

VMD earnings dates

Next earnings date
Aug 6, 2025

Viemed Healthcare Earnings Reports & History FAQ

What were Viemed Healthcare's earnings last quarter?

On VMD's earnings call on Invalid Date, Viemed Healthcare (NASDAQ: VMD) reported Q1 2025 earnings per share (EPS) of $0.07, up 75% year over year. Total VMD earnings for the quarter were $2.63 million. In the same quarter last year, Viemed Healthcare's earnings per share (EPS) was $0.04.

If you're new to stock investing, here's how to buy Viemed Healthcare stock.

When does Viemed Healthcare report earnings?

The next VMD earnings call is Invalid Date. Add VMD to your watchlist to be reminded of Viemed Healthcare's next earnings date.

Is Viemed Healthcare profitable or losing money?

As of the last Viemed Healthcare earnings report, Viemed Healthcare is currently profitable. Viemed Healthcare's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $12.29 million, a 18.96% increase year over year.

What was VMD's earnings growth in the past year?

As of Viemed Healthcare's earnings date in Invalid Date, Viemed Healthcare's earnings has grown 18.52% year over year. This is 32.27 percentage points lower than the US Medical Devices industry earnings growth rate of 50.78%. VMD earnings in the past year totalled $12.29 million.

What are Viemed Healthcare's earnings expectations?

The current EPS estimate for Viemed Healthcare's earnings report in Invalid Date is $0.09.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.